Vaxil Biotherapeutics is developing a revolutionary new treatment for cancer called ImMucin.
ImMucin is a new type of drug called a therapeutic vaccine. A therapeutic vaccine harnesses the power of the body’s immune system to fight cancer.
A therapeutic vaccine teaches the body’s immune system to attack the ‘bad’ cancer cells while the good healthy cells are left untouched.
So the treatment has very low side effects like any other vaccine.
And at the same time because the treatment only attacks the cancer cells, it promises to be much more effective.